Cell-permeating α-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells

Molecular and Cellular Biology

Volumn 27, Issue 9, 2007, Pages 3282-3289

  MacKenzie, Elaine D ^a   Selak, Mary A ^a   Tennant, Daniel A ^a   Payne, Lloyd J ^c   Crosby, Stuart ^c   Frederiksen, Casper M ^a,d   Watson, David G ^b   Gottlieb, Eyal ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c Langford House   (United Kingdom)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; SUCCINATE DEHYDROGENASE; TRICARBOXYLIC ACID;

ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CELL HYPOXIA; CELL LINE; CELL MEMBRANE PERMEABILITY; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KETOGLUTARIC ACIDS; MOLECULAR STRUCTURE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; SUCCINATE DEHYDROGENASE; UBIQUITIN;

EID: 34247553146     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01927-06     Document Type: Article

References (30)

1. Albayrak, T., V. Scherhammer, N. Schoenfeld, E. Braziulis, T. Mund, M. K. Bauer, I. E. Scheffler, and S. Grimm. 2003. The tumor suppressor cybL, a component of the respiratory chain, mediates apoptosis induction. Mol. Biol. Cell. 14:3082-3096.
2. Astrom, K., J. E. Cohen, J. E. Willett-Brozick, C. E. Aston, and B. E. Baysal. 2003. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Hum. Genet. 113:228-237.
3. Bensaad, K., A. Tsuruta, M. A. Selak, M. N. Vidal, K. Nakano, R. Bartrons, E. Gottlieb, and K. H. Vousden. 2006. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126:107-120.
4. Covello, K. L., and M. C. Simon. 2004. HIFs, hypoxia, and vascular development. Curr. Top. Dev. Biol. 62:37-54.
5. Dahia, P. L. M., K. N. Ross, M. E. Wright, C. Y. Hayashida, S. Santagata, M. Barontini, A. L. Kung, G. Sanso, J. F. Powers, A. S. Tischler, R. Hodin, S. Heitritter, F. J. Moore, R. Dluhy, J. A. Sosa, I. T. Ocal, D. E. Benn, D. J. Marsh, B. G. Robinson, K. Schneider, J. Garber, S. M. Arum, M. Korbonits, A. Grossman, P. Pigny, S. P. A. Toledo, V. Nose, C. Li, and C. D. Stiles. 2005. A HIF1α regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet. 1:e8.
6. Domagala, J. M. 1980. A mild, rapid and convenient esterification of -keto acids. Tetrahedron Lett. 21:4997.
7. Gerald, D., E. Berra, Y. M. Frapart, D. A. Chan, A. J. Giaccia, D. Mansuy, J. Pouyssegur, M. Yaniv, and F. Mechta-Grigoriou. 2004. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118:781-794.
8. Gimenez-Roqueplo, A. P., J. Favier, P. Rustin, J. J. Mourad, P. F. Plouin, P. Corvol, A. Rotig, and X. Jeunemaitre. 2001. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am. J. Hum. Genet. 69:1186-1197.
9. Gimenez-Roqueplo, A. P., J. Favier, P. Rustin, C. Rieubland, V. Kerlan, P. F. Plouin, A. Rotig, and X. Jeunemaitre. 2002. Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. J. Clin. Endocrinol. Metab. 87:4771-4774.
10. Gottlieb, E., and I. P. Tomlinson. 2005. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat. Rev. Cancer 5:857-866.
11. Hirsila, M., P. Koivunen, V. Gunzler, K. I. Kivirikko, and J. Myllyharju. 2003. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278:30772-30780.
12. Huang, J., Q. Zhao, S. M. Mooney, and F. S. Lee. 2002. Sequence determinants in hypoxia-inducible factor-1α for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J. Biol. Chem. 277:39792-39800.
13. Isaacs, J. S., Y. J. Jung, D. R. Mole, S. Lee, C. Torres-Cabala, Y. L. Chung, M. Merino, J. Trepel, B. Zbar, J. Toro, P. J. Ratcliffe, W. M. Linehan, and L. Neckers. 2005. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8:143-153.
14. Ishii, T., K. Yasuda, A. Akatsuka, O. Hino, P. S. Hartman, and N. Ishii. 2005. A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis. Cancer Res 65:203-209.
15. Kim, W. Y., and W. G. Kaelin. 2004. Role of VHL gene mutation in human cancer. J. Clin. Oncol. 22:4991-5004.
16. King, A., M. A. Selak, and E. Gottlieb. 2006. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25:4675-4682.
17. Lee, S., E. Nakamura, H. Yang, W. Wei, M. S. Linggi, M. P. Sajan, R. V. Farese, R. S. Freeman, B. D. Carter, W. G. Kaelin, Jr., and S. Schlisio. 2005. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8:155-167.
18. Messner, K. R., and J. A. Imlay. 2002. Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase. J. Biol. Chem. 277:42563-42571.
19. Pollard, P., N. Wortham, E. Barclay, A. Alam, G. Elia, S. Manek, R. Poulsom, and I. Tomlinson. 2005. Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome. J. Pathol. 205:41-49.
20. Pollard, P. J., J. J. Briere, N. A. Alam, J. Barwell, E. Barclay, N. C. Wortham, T. Hunt, M. Mitchell, S. Olpin, S. J. Moat, I. P. Hargreaves, S. J. Heales, Y. L. Chung, J. R. Griffiths, A. Dalgleish, J. A. McGrath, M. J. Gleeson, S. V. Hodgson, R. Poulsom, P. Rustin, and I. P. Tomlinson. 2005. Accumulation of Krebs cycle intermediates and over-expression of HIFla in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14:2231-2239.
21. Safran, M., and W. G. Kaelin, Jr. 2003. HIF hydroxylation and the mammalian oxygen-sensing pathway. J. Clin. Investig. 111:779-783.
22. Schofield, C. J., and P. J. Ratcliffe. 2004. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell. Biol. 5:343-354.
23. Selak, M. A., S. M. Armour, E. D. MacKenzie, H. Boulahbel, D. G. Watson, K. D. Mansfield, Y. Pan, M. C. Simon, C. B. Thompson, and E. Gottlieb. 2005. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7:77-85.
24. Selak, M. A., R. V. Duran, and E. Gottlieb. 2006. Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells. Biochim. Biophys. Acta 1757:567-572.
25. Semenza, G. L. 2002. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8:S62-S67.
26. -, oxidative stress, and genomic instability. Cancer Res. 66:7615-7620.
27. Takeuchi, Y., Y. Nagao, K. Toma, Y. Yoshikawa, T. Akiyama, H. Nishioka, H. Abe, T. Harayama, and S. Yamamoto. 1999. Synthesis and siderophore activity of vibrioferrin and its diastereomeric isomer. Chem. Pharm. Bull. 47:1284-1287.
28. Vanharanta, S., P. J. Pollard, H. J. Lehtonen, P. Laiho, J. Sjoberg, A. Leminen, K. Aittomaki, J. Arola, M. Kruhofer, T. F. Orntoft, I. P. Tomlinson, M. Kiuru, D. Arango, and L. A. Aaltonen. 2006. Distinct expression profile in fumarate-hydratase-deficient uterine fibroids. Hum Mol. Genet. 15:97-103.
29. Williamson, J. R., and B. E. Corkey. 1979. Assay of citric acid cycle intermediates and related compounds - update with tissue metabolite levels and intracellular distribution. Methods Enzymol. 55:200-222.
30. Yankovskaya, V., R. Horsefield, S. Tornroth, C. Luna-Chavez, H. Miyoshi, C. Leger, B. Byrne, G. Cecchini, and S. Iwata. 2003. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science 299: 700-704.